mRNA Platform Innovations Beyond Vaccines

mRNA platform innovations expanding beyond vaccines in biotechnology research

Messenger RNA technology moved into global focus during the COVID-19 vaccine rollout, but the platform’s scientific potential extends well beyond infectious disease prevention. Biotechnology companies, academic labs, and investors are increasingly investigating mRNA as a programmable therapeutic modality capable of addressing oncology, rare diseases, and regenerative medicine. The underlying appeal lies in the platform’s flexibility. … Read more

RNA-Based Therapeutics and Their Expanding Market

RNA based therapeutics research and biotechnology development concept

RNA-based therapeutics have moved from experimental molecular biology to a rapidly expanding segment of the pharmaceutical industry. Advances in RNA chemistry, delivery technologies, and manufacturing scalability are enabling therapies that directly modulate gene expression rather than targeting proteins alone. This shift is reshaping drug development strategies across rare diseases, oncology, metabolic disorders, and infectious disease … Read more